Virtus ETF Advisers’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-8,270
| Closed | -$342K | – | 505 |
|
|
2024
Q4 | $342K | Sell |
8,270
-4,074
| -33% | -$168K | 0.14% | 211 |
|
|
2024
Q3 | $481K | Hold |
12,344
| – | – | 0.23% | 183 |
|
|
2024
Q2 | $422K | Buy |
12,344
+1,329
| +12% | +$45.4K | 0.21% | 183 |
|
|
2024
Q1 | $277K | Buy |
11,015
+1,585
| +17% | +$39.8K | 0.15% | 229 |
|
|
2023
Q4 | $278K | Sell |
9,430
-1,309
| -12% | -$38.6K | 0.18% | 229 |
|
|
2023
Q3 | $339K | Sell |
10,739
-1,390
| -11% | -$43.9K | 0.21% | 193 |
|
|
2023
Q2 | $314K | Sell |
12,129
-4,960
| -29% | -$128K | 0.19% | 193 |
|
|
2023
Q1 | $410K | Buy |
17,089
+299
| +2% | +$7.18K | 0.23% | 145 |
|
|
2022
Q4 | $327K | Buy |
16,790
+4,472
| +36% | +$87.2K | 0.17% | 235 |
|
|
2022
Q3 | $259K | Buy |
12,318
+181
| +1% | +$3.81K | 0.1% | 286 |
|
|
2022
Q2 | $236K | Buy |
12,137
+976
| +9% | +$19K | 0.09% | 308 |
|
|
2022
Q1 | $246K | Sell |
11,161
-656
| -6% | -$14.5K | 0.11% | 186 |
|
|
2021
Q4 | $188K | Sell |
11,817
-167
| -1% | -$2.66K | 0.07% | 234 |
|
|
2021
Q3 | $239K | Sell |
11,984
-618
| -5% | -$12.3K | 0.11% | 224 |
|
|
2021
Q2 | $218K | Buy |
12,602
+87
| +0.7% | +$1.51K | 0.09% | 284 |
|
|
2021
Q1 | $248K | Buy |
12,515
+223
| +2% | +$4.42K | 0.1% | 290 |
|
|
2020
Q4 | $215K | Sell |
12,292
-5,166
| -30% | -$90.4K | 0.09% | 338 |
|
|
2020
Q3 | $336K | Sell |
17,458
-2,377
| -12% | -$45.7K | 0.18% | 200 |
|
|
2020
Q2 | $386K | Buy |
+19,835
| New | +$386K | 0.18% | 214 |
|